NASH Clinical Trials

65 clinical trials for NASH across international registries, including 13 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Digoxin In NASH (CODIN) — RECRUITING · PHASE2
• Androgens and NAFLD Longitudinal Cohort Study — RECRUITING
• Trial of CS060380 Tablets for Non-alcoholic Steatohepatitis (NASH) — RECRUITING · PHASE2
• Evaluation of Risk of hEpatocellular Carcinoma — RECRUITING · NA
• To Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BAR502 in Healthy Subjects — RECRUITING · PHASE1
• a Safety, Tolerability, and Pharmacokinetic Trial of Multiple Subcutaneous Injections of B1344 Injection in Patients With Nonalcoholic Fatty Liver Disease（NAFLD） — RECRUITING · PHASE1
• Evaluation of a New Ultrasound System for the Non-invasive Assessment of Liver Steatosis in MASLD/MASH Patients — RECRUITING · NA
• Evaluation of Non-Invasive Tests for Metabolic Liver Disease — RECRUITING
• Optimizing Noninvasive assessMent Of DysmEtabolic Compensated Advanced Liver Disease — RECRUITING · NA
• Secondary and Tertiary Digital Prevention of Non-alcoholic and Dysmetabolic Liver Disease — RECRUITING
• HuHuangLianzonggan Capsule in Subjects With Nonalcoholic Steatohepatitis: a Phase 2 tRial(HHL-HEPAR) — RECRUITING · PHASE2
• Role of the Very Low Calorie Ketogenic Diet (VLCKD) in Patients With Non-Alcoholic Steatohepatitis (NASH) With Fibrosis — RECRUITING · NA
• The European NAFLD Registry — RECRUITING
• Hyperpolarized Pyruvate (13C) Magnetic Resonance Imaging In Patients With Fatty Liver Disease — COMPLETED
• Assessment of Fatty Liver With Thermo-acoustic Device — WITHDRAWN
• Early Liver Disease Breath Detection — COMPLETED
• A Phase 3 Study to Evaluate the Effect of Resmetirom on Clinical Outcomes in Patients With Well-compensated NASH Cirrhosis (MAESTRO-NASH-OUTCOMES) — ACTIVE_NOT_RECRUITING · PHASE3
• Study to Evaluate the Efficacy and Safety of K-877-ER and CSG452 in Participants With NASH With Liver Fibrosis — COMPLETED · PHASE2
• A Phase 3 Study Evaluating the Safety and Efficacy of HSK31679 in Patients With MASH — NOT_YET_RECRUITING · PHASE3
• Effects of Phytosterol Supplementation on Liver Function and Inflammatory Status in Patients With Nonalcoholic Fatty Liver Disease — COMPLETED · NA
• A Study to Evaluate DD01 in Overweight/Obese Subjects With MASLD/MASH — COMPLETED · PHASE2
• Study to Determine the Response to COVID-19 Vaccination and Prevalence of COVID-19 in Subjects With Chronic Liver Disease — COMPLETED
• RE and Probiotics in MAFLD/NAFLD — NOT_YET_RECRUITING · NA
• Feasibility, Safety and Acceptability of a Mobile Health Delivered Exercise Training Program in Patients With Nonalcoholic Steatohepatitis — COMPLETED · NA
• A Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of VSA006 in Chinese NASH Patients — ACTIVE_NOT_RECRUITING · PHASE2
• A Phase 2 Study of Elobixibat in Adults With NAFLD or NASH — COMPLETED · PHASE2
• An Imaging-based Quantitative Biomarker Assay for NAFLD in Children — ACTIVE_NOT_RECRUITING · NA
• Screening of Liver Fibrosis Using Blood Tests in Patients With Type 2 Diabetes Mellitus — COMPLETED · NA
• Clinical research trial for evaluating different properties, such as safety, tolerability and body interaction, of a new drug called ALY688ER, administered as subcutaneous injection in healthy overweight or obese people. — NOT_YET_RECRUITING · PHASE1
• Digital Therapeutic Lifestyle Intervention Program for Patients With MASLD — WITHDRAWN · NA
• Knockdown of HSD17B13 mRNA, Pharmacokinetics, Safety, and Tolerability, of AZD7503 in Non-Alcoholic Fatty Liver Disease — COMPLETED · PHASE1
• A Phase 3 Study Evaluating the Safety and Efficacy of Denifanstat in Patients With MASH and F2/F3 Fibrosis — WITHDRAWN · PHASE3
• A Phase 3 Study Evaluating the Safety and Efficacy of Denifanstat in Patients With MASLD and MASH — WITHDRAWN · PHASE3
• LITMUS Imaging Study — ACTIVE_NOT_RECRUITING
• Phase 1 Study to Evaluate the Safety and Tolerability of VK2735 — COMPLETED · PHASE1
• ALG-055009 in Non-cirrhotic Adults With MASH (HERALD) — COMPLETED · PHASE2
• A Clinical Trial of BGT-002 Tablets in Subjects With Nonalcoholic Steatohepatitis — COMPLETED · PHASE1
• Precise Evaluation Criteria for Histological Regression of NASH Fibrosis — NOT_YET_RECRUITING
• A Phase II Clinical Trial of Chiglitazar for NASH — COMPLETED · PHASE2
• A Study of ALN-HSD in Healthy Adult Subjects and Adult Patients With Nonalcoholic Steatohepatitis (NASH) — TERMINATED · PHASE1
• Effect of Dipeptidyl Peptidase- 4 Inhibitors on Non-Alcoholic Steatohepatitis and Type 1 Diabetes — COMPLETED · PHASE3
• The Impact of Different Carbohydrate Restriction After a Gastric Bypass on the Ketosis and Ketoacidosis — OTHER · NA
• A Multiple Ascending Dose Study of Pegozafermin in Participants With Biopsy Confirmed Nonalcoholic Steatohepatitis (NASH) or Nonalcoholic Fatty Liver Disease (NAFLD) and at High Risk of NASH — COMPLETED · PHASE1
• A Multicenter, Double-blind, Placebo-randomized Controlled Clinical Study on the Treatment of Non-alcoholic Steatohepatitis With Tibetan Drug Langqing Atar — OTHER · NA
• DIAbetes and NAFLD — ACTIVE_NOT_RECRUITING
• The Visceral Adiposity Measurement and Observation Study — COMPLETED
• Effects of Online App Weight Loss Programs on Liver Health in Obese Adults — COMPLETED · NA
• Psoriasis and Non Alcoholic Steatohepatitis: Is There a Shared Inflammatory Network ? — OTHER
• An Open-Label, Two-Part Study Designed to Assess the Absolute Bioavailability and Mass Balance of Aramchol — COMPLETED · PHASE1
• Study Consortium for Evaluation of RNPC Program in Obese and Overweight Patients (SCOOP-RNPC) — NOT_YET_RECRUITING

Refine this search